Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology - United States
doi 10.1016/j.urology.2008.05.032
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2006English

Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
1996English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2005English

A Phase-Ii Study of Combination of Pegylated Interferon Alfa-2a and Capecitabine in Locally Advanced or Metastatic Renal Cell Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy